The newly identified ST164 strain of antibiotic-resistant CRAB bacteria is spreading in Asia, posing a global health risk due to high resistance and limited treatment options. Rigorous infection control and genomic monitoring are critical to containing its spread.
A new study reveals that a highly virulent strain of antibiotic-resistant bacteria, which causes severe illness, may be spreading widely across Asia, creating serious challenges for global public health.
Researchers identified the ST164 variant of Carbapenem-resistant Acinetobacter baumannii (CRAB) in a Chinese intensive care unit (ICU) while investigating the impact of bundled infection prevention and control (IPC) measures on the spread of CRAB.
Over a three-month period in 2021, the experts conducted extensive genomic surveillance, within the ICU in Hangzhou, revealing that 80.9% of the or A. baumannii bacteria found in patients were CRAB, with ST164 accounting for 40.2% of samples.
Publishing their findings in Nature Communications, researchers from the University of Birmingham and Zhejiang University reveal that other hospital wards and transferred patients could be sources of new CRAB strains entering the ICU.
The study follows the team’s previous research at the Hangzhou ICU in 2019, which showed that almost one-third of patients were infected by CRAB.
Latest research shows one strain type (GC2) among CRAB isolates fell from 99.5% in 2019 to 50.8% in 2021. The remaining population mainly consisted of ST164 isolates that have been evolving since mid-2020 and have twice the levels of measurable resistance to carbapenems that the GC2 strains have.
Rising Resistance and Need for Careful Monitoring
Co-author Professor Alan McNally, from the University of Birmingham, commented: “We believe that ST164 is becoming established in ICU settings and may be spreading widely across Asia. While ST164 caused fewer infections than GC2 during the study period, its high levels of antibiotic resistance indicate it needs careful monitoring.
“CRAB poses a serious risk to hospitalized patients and can cause severe disease including pneumonia, urinary tract infection, bacteraemia, meningitis, and soft tissue infections. Ongoing IPC measures are vital for controlling these bacteria’s spread within hospitals and further research is needed to understand how these strains evolve in hospital environments.”
The research was supported by funding from the Medical Research Council and the National Natural Science Foundation of China. The study involved high-resolution whole-genome sequencing and comparative analysis of CRAB isolates.
CRAB can persist for prolonged periods on hospital surfaces and medical equipment and colonize patients within 48 hours of admission – facilitated by hospital staff, shared equipment, airflow, and plumbing. Outbreaks of CRAB can require interventions or changes to infrastructure that impose clinical, logistical, and financial burdens.
Global Public Health Threat and Urgent Need for New Treatments
Antibiotic-resistant infections are a major threat to global public health. CRAB infections are found worldwide with severely limited treatment options prompting the World Health Organisation to designate CRAB a priority organism for which novel therapeutics are urgently required.
Co-author Professor Willem van Schaik, from the University of Birmingham, added: “The health implications of CRAB, especially the ST164 clone, are profound, affecting patient outcomes, healthcare systems, and public health globally. In the absence of new therapeutic agents, effective CRAB IPC strategies are vital if we are to limit the morbidity and mortality caused by the bacteria in hospitals. In addition, our study illustrates the power of genomic surveillance to map the emergence and dissemination of this drug-resistant clone.”
Reference: “Longitudinal genomics reveals carbapenem-resistant Acinetobacter baumannii population changes with emergence of highly resistant ST164 clone” by Haiyang Liu, Robert A. Moran, Emma L. Doughty, Xiaoting Hua, Ann E. Snaith, Linghong Zhang, Xiangping Chen, Feng Guo, Willem van Schaik, Alan McNally and Yunsong Yu, 2 November 2024, Nature Communications.
DOI: 10.1038/s41467-024-53817-x
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
4 Comments
Thanks Wuhan. But you’re too late. We already elected DJT. Democrats are apoplectic.
I dont know how to upvote on this platform but TWO thumps up Doc.
Wonder if the development of all of these new super-bugs was funded by USAID.
oh goodie. another gift from Asia to the Free World.